This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Re: Two Centres’ Experience With Lung Cancer Resection in Patients With Advanced Non-Small-Cell Lung Cancer Following Treatment With Immune Checkpoint Inhibitors: Safety and Clinical outcomes

Friday, August 27, 2021

Submitted by


Source Name: European Journal of Cardio-Thoracic Surgery


Bertrand Mennecier, Anne Olland, Céline Mascaux, Pierre-Emmanuel Falcoz
This invited commentary offers insights into a manuscript that provides a deeper understanding of the perioperative outcomes of patients with stage II/IV non-small-cell lung cancer (NSCLC) with tumour resection after neoadjuvant immunotherapy, alone or as part of multimodal treatment.

Add comment

Log in or register to post comments